Characterization of the metabolism of perinecrotic cells in solid tumors by enzyme histochemistry

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1491-1502

  Freitas, Isabel ^a   Bono, Barbara ^a   Bertone, Vittorio ^a   Griffini, Patrizia ^a   Baronzio, Gian Franco ^b   Bonandrini, Luigi ^a   Gerzeli, Giuseppe ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Oncology Section   (Italy)

Author keywords

Acid phosphatase; Dihydrofolate reductase; Glucose 6 phosphate dehydrogenase; Lactate dehydrogenase; Purine nucleoside phosphorylase; Succinate dehydrogenase; Tumor hypoxia; Xanthine oxidoreductase

Indexed keywords

ACID PHOSPHATASE; DIHYDROFOLATE REDUCTASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LACTIC ACID; PURINE NUCLEOSIDE PHOSPHORYLASE; SUCCINATE DEHYDROGENASE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL DEATH; CELL METABOLISM; CONFERENCE PAPER; EHRLICH ASCITES TUMOR; ENZYME HISTOCHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ACID PHOSPHATASE; ANIMALS; CARCINOMA, EHRLICH TUMOR; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; L-LACTATE DEHYDROGENASE; MICE; NECROSIS; PURINE-NUCLEOSIDE PHOSPHORYLASE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0030056668     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (97)

1. Rockwell S: Hypoxic cells as targets for cancer therapy. In: Cheng YC, Goz B and Minkoff M (eds), Development of Target-Oriented Anticancer Drugs, New York, Raven Press, 1983, pp 101-137.
2. Moulder JE and Rockwell S: Tumor hypoxia: its impact on cancer therapy. Cancer Met Rev 5: 313-341, 1987.
3. Freitas I and Baronzio GF: Tumor hypoxia, reoxygenation and oxygenation strategies: possible role in photodynamic therapy. J Photochem Photobiol B: Biol 11: 3-30, 1991.
4. Gullino PM: Extracellular compartments of solid tumors. In: (Becker FF, ed) Cancer: A Comprehensive Treatise, Vol 3, New York, Plenum Press, 1975. pp 327-354.
5. Jain RK: Vascular and interstitial harriers to delivery of therapeutic agents in tumors. Cancer Met Rev 9: 253-266, 1990.
6. Boucher Y and Jain R: Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52: 5110-5114, 1992.
7. Denekamp J and Fowler JF: Cell proliferation kinetics and radiation therapy. In: Becker FF (ed) Cancer: A Comprehensive Treatise, Vol. 6. New York, Plenum Press, 1977, pp 101-137.
8. Freitas I, Baronzio GF, Bertone V, Griffini P, Gerzeli G, Pontiggia P and Stoward PJ: Stroma formation in Ehrlich carcinoma. I. Oedema phase. A mitosis burst as an index of physiological reoxygenation? Anticancer Res 11: 569-578, 1991.
9. Gray JW: Quantitative cytokinetics: cellular response to cell cycle specific agents. In: Dethlefsen LA (ed) Cell Cycle Effect of Drugs, Oxford, Pergamon Press, 1986, pp 44-84.
10. Lundy J, Lovett EJ, Lipow D and Whitte C: Anesthesia, surgery, immunosuppression, and tumor growth. In: Stewart THM and EF Wheelock (eds) Cellular Immune Mechanisms and Tumor Dormancy, Boca Raton. CRC Press, 1992, pp 155-167.
11. Demichelli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M and Bonadonna G: Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 86: 45-48, 1994.
12. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1: 149-153, 1995.
13. Holmgren L, O'Reilly M and Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1: 149-153, 1995.
14. Wilson RE, Keng PC and Sutherland RM: Changes in growth characteristics and macromolecular synthesis on recovery from severe hypoxia. Br J Cancer 61: 14-21, 1989.
15. Young SD and Hill RP: Effects of reoxygenation on cells from hypoxic regions of solid tumors: analysis of transplanted murine tumors for evidence of DNA overreplication. Cancer Res 50: 5031-5038, 1990.
16. Rice GC, Hoy C and Schimke RT: Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83: 5978-5982, 1986.
17. Brown JM: Tumor hypoxia, drug resistance and metastases. J Natl Cancer Inst 82: 338-339, 1990.
18. Anderson JR (ed) Muir's Textbook of Pathology, London, Edward Arnold, 1985, pp 4.25-4.27.
19. 1H MR Imaging. Am J Radiol 158: 259-264,1992.
20. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger and Dvorak HF: Expression of Vascular Permeability Factor (Vascular Endothelial Growth Factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735, 1993.
21. Senger DR, van de Water L, Brown, Nagy JA, Yeo K-T, Yeo TK, Berse B, Jackman RW, Dvorak AM and Dvorak HF: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Met Rev 12: 303-324, 1993 .
22. Shweiki D, Itin A, Soffer D and Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
23. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
24. Overgaard J, Grau C, Lindegaard JC and Horsman MR: The potential of using hyperthermia to eliminate radioresistant hypoxic cells. Radiother Oncol (Suppl) 20: 113-116, 1991.
25. Bioreductive Drugs for Cancer Therapy. Cancer Met Rev 12: 73-211, 1993.
26. Hutner SH and Marcus SL: Protozoological approaches to the cellular basis of mammalian stress repair. Int Rev Cytol 100: 371-425,1987.
27. Farber E and Rubin H: Cellular adaptation in the origin and development of cancer. Cancer Res 51: 2751-2761,1991.
28. Mueller-Klieser W and Watenta S: Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Histochem J 25: 407-420, 1993.
29. Sutherland R, Freyer J, Mueller-Klieser W, Wilson R, Heacock C, Sciandra J and Sordat B: Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions. Int J Radiat Oncol Biol Phys 12: 611-615,1986.
30. Heacock CS and Sutherland RM: Induction characteristics of oxygen regulated proteins. Int J Radiat Oncology Biol Phys 12: 1287-1290, 1986.
31. Heacock CS and Sutherland RM: Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br J Cancer 62: 217-225, 1990.
32. Anderson GR and Farkas BK: Major anoxic stress response protein p34 is a distinct lactate dehydrogenase. Biochemistry 27: 2187-2193, 1988.
33. Weber G: Enzymology of cancer cells (first of two parts). N Eng J Med 296: 486-493, 1977.
34. Weber G: Enzymology of cancer cells (secondof two parts). N Eng J Med 296: 541-551, 1977.
35. Freitas I, Pontiggia P, Barni S, Bertonc V, Parente M, Novarina A, Roveta G, Gerzeli G and Stoward PJ: Histochemical probes for detection of hypoxic cells. Anticancer Res 10: 611-620, 1990.
36. Freitas I, Bertone V, Griffini P, Baronzio GF, Pontiggia P and Stoward PJ: In situ lactate dehydrogenase patterns as markers of tumor oxygenation. Anticancer Res 11: 1293-1300, 1991.
37. Van Noorden CJF and Butcher RG: Histochemical localization of NADP-dependent dehydrogenase activity with four different tetrazolium salts. J Histochem Cytochem 32: 998-1004, 1984.
38. Eigenbrodt E, Gerbracht U, Mazurek S, Presek P and Friis R: Carbohydrate metabolism and neoplasia: new perspectives for diagnosis and therapy. In: Pretlow II TG and Pretlow TP (eds). Biochemical and Molecular Aspect of Selected Cancers. San Diego, Academic Press. 1994, pp 311-385.
39. Kooij A, Bosch KS, Fredeiks WM and Van Noorden CJF: High levels of xanthine oxidoreductase in rat endothelial, epithelial and connective tissue cells. A relation between localization and function? Virchows Arch B: Cell Pathol 62: 143-150, 1992.
40. Borgers M, Firth JA, Stoward PJ and Verheyen A: Phosphatases. In: Stoward PJ and Pearse AGE (eds). Histochemistry. Theoretical and Applied. vol. 3, Edinburgh, Churchill Livingstone, 1991, pp 187-218.
41. Frederiks WM, Ouwerkerk IJM, Bosch KS, Marx F, Kooij A and Van Noorden CJF: The effects of storage on the retention of enzyme activity in cryostat sections. A quantitative histochemical study on rat liver. Histochem J 25: 119-122, 1993.
42. Kugler P: Quantitative dehydrogenase activity with exogenous electron carriers (PMS, MPMS, MB). Histochemistry 75: 99-112, 1982.
43. Lluis C: Lactate dehydrogenase associated with the mitochondrial fraction and with a mitochondrial inhibitor. I. Enzyme binding to the mitochondrial fraction. Int J Biochem 16: 997-1004, 1984.
44. Appling DR: Compartmentation of folate-mediated one-carbon metabolism in eucaryotes. FASEB J 5: 2645-2651, 1991.
45. Van Noorden CJF, Vogels IMC, Everts V and Beertsen W:. Enzyme cytochemistry of unfixed leukocytes and bone marrow cells using polyvinyl alcohol for the diagnosis of leukemia. Histochemistry 92: 313-318, 1989.
46. Van Noorden CJF and Frederiks WM: Enzyme histochemistry. A Laboratory Manual of Current Methods. Oxford, Oxford Science Publications, 1992.
47. Freitas I, Griffini P, Bono B, Bertone V and Gerzeli G: A two-step method for the demonstration of Dihydrofolate Reductase activity in the liver. Proc XXXVI Symp Society for Histochemistry, Sept 1994, p 53.
48. Frederiks WM, Bosch KS and Van Gulik T: A quantitative histochemical procedure for the demonstration of purine nucleoside phosphorylase activity in rat and human liver using tetranitro BT and xanthine oxidase as auxiliary enzyme. Histochem J 25: 86-91, 1993.
49. Gabbert H, Wagner R, Moli R and Germarz C-D: Tumor dedifferentiation: an important step in tumor invasion. Clin Expl Metastasis 3: 257-279, 1985.
50. WadsworthRM: Vasoconstrictor and vasodilator effects of hypoxia. TIPS 15: 47-53, 1994.
51. Cheville NF: Cell Pathology, Ames, Iowa State University Press, 1983, pp 61, 76-77, 92-95, 123124, 141-142.
52. Ringstead S and Robinson GB: Cell culture from rat renal glomeruli. Virchows Archiv 425: 391-398, 1994.
53. Alberts B, Bray D, Lewis J, Raff M, Roberts K and Watson JD: Molecular Biology of the Cell, New York, Garland Publishing, 1994, pp 863-999, 1139-1142.
54. Mueller-Klieser W: Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol 113: 101-172, 1987.
55. Acosta D and Wenzel DG: A permeability test for the study of mitochondrial injury in in vitro cultured heart muscle and endothlioid cells. Histochem J 7: 45-56, 1975.
56. Hale TW and Wenzel DG: Quantitation of mitochondrial injury in cultured heart endothelial cells with nitrablue tetrazolium. Histochem J 10: 409-415, 1978.
57. Scidler E: The tetrazolium-formazan system: design and histochemistry. Progr Histochem Cytochem 24: 1 -79, 1991.
58. Kakari S: Observations on the use of nitro blue tetrazolium in the detection of early myocardial changes. Histochem J 2: 453-477, 1970.
59. Griffini P, Vigorelli E, Bertone V, Freitas I and Van Noorden CJF: Quantitative comparison between the gel-film and polyvinyl alcohol methods for dehydrogenase histochemistry reveals different intercellular distribution patterns of glucose-6-phosphate and lactate dehydrogenases in mouse liver. Histochem J 26: 480-486, 1994.
60. Darzinkiewicz Z, Rogers AW, Barnard EA, Wang D-H and Werkheiser W: Autoradiography with tritiated methotrexate and the cellular distribution of folate reductase. Science 151: 1528-1530, 1966.
61. Schwarzacher HG and Wachtler F: The nucleolus. Anat Embryol 188: 515-536, 1993.
62. Wachtler F and Stahl A: The nucleolus: a structural and functional interpretation. Micron 24: 473-505, 1993.
63. Scherini E and Mares V: Renewal of DNA in Purkinje cell nuclei of mouse cerebellum. A 9-month follow-up autoradiographical study. Physiol Res 42: 193-199, 1993.
64. Van Noorden CJF: Histochemistry and cytochemistry of glucose-6-phosphate dehydrogenase. Progr Histochem Cytochem 15: 1-85, 1984.
65. Griffini P, Freitas I, Vigorelli E and Van Noorden CJF: Changes in the zonation of lactate dehydrogenase activity in lobules of rat liver after experimentally induced colon carcinoma metastases. Anticancer Res 14: 2537-2540, 1994.
66. Eigenbrodt E and Glossman H: Glycolysis - one of the keys to cancer? Trends Pharmacol Sci May: 240-245, 1980.
67. Eigenbrodt E, Fister P and Reinacher M: New Perspectives on carbohydrate metabolism in tumor cells. In: Bcitncr R (ed) Regulation of Carbohydrate Metabolism, Vol III, Boca Raton, CRC Press, 1985, pp 141-179.
68. Kovacevic and Morris HP: The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 32: 326-333, 1972.
69. Sauer LA, Webster Steinman II J and Dauchy RT: Amino acid. glucose and lactic acid utilization in vivo by rat tumors. Cancer Res 42: 4090-4097, 1982.
70. Sauer LA and Dauchy RT: Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats. Cancer Res 43: 3497-3503, 1983.
71. Souba WW: Glutamine and cancer. Ann Surg 218: 715-728, 1993.
72. Jungermann K and Katz N: Functional specialization of different hepatocyte populations. Physiol Rev 69: 708-764, 1989.
73. Gullans SR and Hebert SC: Metabolic basis of ion transport. In: Brenner BM and Rector FC (eds) The Kidney, Philadelphia, Saunders and Co, 1991, pp 76-109.
74. Knapp WH: Pathomechanisms of the cerebral and myocardial glucose metabolism. Nucl-Med 29: 236-245, 1990.
75. Hrabac B, Catovic Dz and Nikulin A: Lactate dehydrogenase isoenzymes in human malignant tumors. Neoplasma 31: 299-305, 1984.
76. Nishikawa A, Tanaka T, Takeuchi T, Fujihiro S and Mori H: The diagnostic significance of lactate dehydrogenase isoenzymes in urinary cytology. Br J Cancer 63: 819-821, 1991.
77. Seidman I: Ion movements in liver tissue. I: Bittar EE (ed) Membranes and Ion Transport, Vol 2, London, Wiley-Interscience, 1970, pp 217-227.
78. Nagy IZ: Cytosomes (yellow pigment granules) of molluscs as cell organelles of anoxic energy production, Int Rev Cytol 49: 331-377, 1977.
79. Ahn YS, Zerban H, Grobholz and Bannasch P: Sequential changes in glycogen content, expression of glucose transporters and enzyme patterns during development of clear/acidophilic cell tumors in rat kidney. Carcinogenesis 13: 2329-2334, 1992.
80. Ahn YS, Zerban H and Bannasch P: Expression of glucose transporter isoforms (GLUT1, GLUT2) and activities of hexokinase, pyruvate kinase, and malic enzyme in preneoplastic and neoplastic rat renal basophilic cell lesions. Virchows Archiv B cell pathol 63: 351-357, 1993.
81. Levine RL: Ischemia: from acidosis to oxidation. FASEB J 7: 1242-1246, 1993.
82. Kallinowski F, Fortmeyer HP, Runkel S and Vaupel P: Substrate utilization of human tumor xenografts in vivo. J Nutrition Growth cancer 4: 155-166, 1987.
83. Salway JG: Metabolism at a Glance, Oxford, Blackwell Scientific Publications, 1994.
84. Bannasch P, Benner U, Hacker H-J, Klimek F, Mayer D, Moore M and Zerban: Cytochemical and biochemical microanalysis of carcinogenesis. Histochem J 13: 799-820, 1981.
85. Baba M, Yamamoto R, Iishi H, Tatsuta M and Wada A: Role of glucose-6-phosphate dehydrogenase on enhanced proliferation of pre-neoplastic and neoplastic cells in rat liver induced by N-nitrosomorpholine. Int J Cancer 43: 892-895, 1989.
86. 31P NMR and enzymatic studies. Anticancer Res 13: 867-872, 1993.
87. Weitman SD, Weingerg AG, Coney LR, Zurwski VR, Jennings DS and Kamen BA: Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 52: 6708-6711, 1992.
88. Kamen VA and Capdevilla A: Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci USA 83: 5983-5987, 1986.
89. Pheasant AE, Bates J, Blair JA and Nayyir-Mazhir R: Investigations of tissue folates in normal and malignant tissue. In: Blair JAD (ed) Chemistry and Biology of Pteridines, Berlin, Walter de Gruyter & Co, 1983, pp 875-878.
90. Melera PW: Acquired versus intrinsic resistance to methotrexate: diversity of the drug-resistant phenotype in mammalian cells. Sem Cancer Biology 2: 245-255, 1991.
91. Natsumeda Y, Prajda N, Donohue J, Glover JL and Weber G: Enzyme capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues. Cancer Res 44: 2475-2479, 1984.
92. Hulstaert CE, Kalicharan D, Poelstra K, Bakker WW and Hardonk MJ: Survey of the occurence of adenosine polyphosphatase in extracellular matrix of rat tissues. Histochemistry 96: 441 -447, 1991.
93. Wattiaux R and Wattiaux-De Coninck S: Effects of ischemia on lysosomes. Int Rev Exp Pathol 26: 85-106, 1984.
94. Reunanen H and Nykanen P: A cytochemical study of the effects of energy deprivation on autophagocytosis in Ehrlich ascites tumor cells. Histochemistry 90: 177-184, 1988.
95. Ericsson JLE: Mechanism of cellular autophagy. In: Dingle JT and Fell HB (eds) Lysosomes in Biology and Pathobiology, Vol 2, Amsterdam, North Holland Publishing Co, 1969, pp 345-394.
96. Williams PL and Wendell-Smith CP: Istituzioni di Embriologia, Milano, Edi. Ermes srl, 1976, pp 96-122.
97. Lala PK and Graham CH: Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Met Rev 9: 369-379, 1990.